Guidance for stem cell therapy for juvenile systemic sclerosis patients
Ivan Foeldvari(Center for Rheumatology), Vanessa Smith(Ghent University Hospital), Kathryn S. Torok(University of Pittsburgh Medical Center), Clarissa Pilkington(Great Ormond Street Hospital), Paulina Horvei(University of Pittsburgh), Patrícia Costa‐Reis(University of Lisbon), Bernd Hinrichs(Asklepios Fachklinikum Brandenburg), Pia Moinzadeh(University of Cologne), Clare Pain(University of Toronto), Suzanne C. Li(Hackensack Meridian Health), Megan L. Curran, Tamás Constantin(Semmelweis University), Christopher P. Denton(The Royal Free Hospital), Juliana Silva(Great Ormond Street Hospital), Maurizio Cutolo, Catherine H. Orteu(Royal Free London NHS Foundation Trust), Susan Maillard(Great Ormond Street Hospital), Kim Fliglstone(National Patient Safety Foundation), Jörg Henes(University of Tübingen), Rosser Franziska(University of Pittsburgh), Linda Schraven
Cited by 8
Related Papers
Long-term Psychological and Occupational Effects of Providing Hospital Healthcare during SARS Outbreak
|Emerging infectious diseases|2006|1.2k
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432